-+ 0.00%
-+ 0.00%
-+ 0.00%

SENTYNL THERAPEUTICS- SENTYNL AND MEREO ENTER OPTION AND LICENSE AGREEMENT FOR ALVELESTAT IN AATD-LD

Reuters·08/11/2026 12:00:07

Please log in to view news